GATM polymorphism associated with the risk for statin-induced myopathy not replicated in case-control analysis of 715 dyslipidemic individuals

Statin-induced myopathy (SIM) is the most common reason for discontinuation of statin therapy. A polymorphism affecting the gene encoding glycine amidinotransferase (GATM rs9806699 G>A) was previously associated with reduced risk for SIM. Our objective was to replicate the GATM association in a l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Metab
Autors principals: Luzum, Jasmine A., Kitzmiller, Joseph P., Isackson, Paul J., Ma, Changxing, Medina, Marisa W., Dauki, Anees M., Mikulik, Eduard B., Ochs-Balcom, Heather M., Vladutiu, Georgirene D.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394188/
https://ncbi.nlm.nih.gov/pubmed/25863251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2015.03.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars